Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers-Reference-Cited by-同舟云学术

Pharmacokinetic Properties of Peramivir After Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers

Published:2016-06-17 Issue:9 Volume:36 Page:705-711
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Zhang Ming,Wang Zhan-Zhang,Ni Xiao-Jia,Li Li-Zhong,Zhang Yue-Feng,Lu Hao-Yang,Peng Huan,Huang Wen-Can,Shen Ling-Fang,Xiong Ling-Hui,Shang De-Wei,Wen Yu-Guan

Funder

National Natural Science Foundation of China

Shanxi Pude Pharmaceuticals Co., Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-016-0417-8.pdf

Reference11 articles.

1. Atiee G, Lasseter K, Baughman S, McCullough A, Collis P, Hollister A, et al. Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans. J Clin Pharmacol. 2012;52:1410–9.

2. Yoshino Y, Seo K, Koga I, Kitazawa T, Ota Y. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan. Clin Respir J. 2015;9:228–32.

3. Kakuta M, Kubo S, Tanaka M, Tobiume S, Tomozawa T, Yamashita M. Efficacy of a single intravenous administration of laninamivir (an active metabolite of laninamivir octanoate) in an influenza virus infection mouse model. Antivir Res. 2013;100:190–5.

4. Matsuo Y, Ishibashi T, Hollister AS, Wajima T. Population pharmacokinetics of peramivir in healthy volunteers and influenza patients. Antimicrob Agents Chemother. 2015;59:6755–62.

5. Bentley ML, Hollistera AS, Hansenb AC, Smith JA, Cain JS. Peramivir pharmacokinetics in a patient receiving continuous veno-venous hemodiafiltration during the 2009 H1N1 influenza A pandemic. Int J Clin Pharmacol Ther. 2014;52:1105–11.